胸部X线评分单独或联合其他风险评分预测COVID-19结局
该回顾性队列研究评估了三种胸片评分系统(RALE、Brixia、百分比实变)在SARS-CoV-2感染患者中的可靠性和预测不良结局的能力。结果显示三种评分均具有良好观察者间信度,且高百分比实变与ICU入住或死亡风险增加相关,联合NEWS2评分可提高预测价值。
要点
- Brixia、RALE和百分比实变评分观察者间信度良好,ICC分别为0.86、0.87和0.72。
- 胸片实变>75%时,ICU入住或死亡的中位时间仅1-2天。
- 校正NEWS2后,实变51%-75%和>75%分别使ICU风险增加2.2倍和4.0倍。
关键影像表现/征象
- 胸片实变百分比>75%的患者ICU入住或死亡的中位时间仅1-2天。
- 实变百分比51%-75%和>75%与0%-25%相比,校正NEWS2后ICU风险分别增加2.2倍和4.0倍。
- 三种评分系统(RALE、Brixia、百分比实变)观察者间信度良好,ICC分别为0.87、0.86和0.72。
诊断标准与关键数值
- RALE评分ICC为0.87(95%CI: 0.80, 0.92)。
- Brixia评分ICC为0.86(95%CI: 0.76, 0.92)。
- 百分比实变评分ICC为0.72(95%CI: 0.48, 0.85)。
- 实变51%-75% vs 0%-25%的HR为2.2(95%CI: 1.6, 2.8)。
- 实变>75% vs 0%-25%的HR为4.0(95%CI: 3.4, 4.7)。
临床应用与阅片要点
- 胸片评分可用于COVID-19患者风险分层,高实变百分比提示需密切监测。
- 联合NEWS2评分可提高预测能力,建议在报告中量化实变范围。
- 注意三种评分系统均需规范使用,确保观察者间一致性。
局限性
- 单中心回顾性研究,样本量有限。
- 仅部分患者(50例)由全部三名放射科医生评分以评估信度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Radiographic severity may help predict patient deterioration and outcomes from COVID-19 pneumonia. Purpose To assess the reliability and reproducibility of three chest radiograph reporting systems (radiographic assessment of lung edema [RALE], Brixia, and percentage opacification) in patients with proven SARS-CoV-2 infection and examine the ability of these scores to predict adverse outcomes both alone and in conjunction with two clinical scoring systems, National Early Warning Score 2 (NEWS2) and International Severe Acute Respiratory and Emerging Infection Consortium: Coronavirus Clinical Characterization Consortium (ISARIC-4C) mortality. Materials and Methods This retrospective cohort study used routinely collected clinical data of patients with polymerase chain reaction-positive SARS-CoV-2 infection admitted to a single center from February 2020 through July 2020. Initial chest radiographs were scored for RALE, Brixia, and percentage opacification by one of three radiologists. Intra- and interreader agreement were assessed with intraclass correlation coefficients. The rate of admission to the intensive care unit (ICU) or death up to 60 days after scored chest radiograph was estimated. NEWS2 and ISARIC-4C mortality at hospital admission were calculated. Daily risk for admission to ICU or death was modeled with Cox proportional hazards models that incorporated the chest radiograph scores adjusted for NEWS2 or ISARIC-4C mortality. Results Admission chest radiographs of 50 patients (mean age, 74 years ± 16 [standard deviation]; 28 men) were scored by all three radiologists, with good interreader reliability for all scores, as follows: intraclass correlation coefficients were 0.87 for RALE (95% CI: 0.80, 0.92), 0.86 for Brixia (95% CI: 0.76, 0.92), and 0.72 for percentage opacification (95% CI: 0.48, 0.85). Of 751 patients with a chest radiograph, those with greater than 75% opacification had a median time to ICU admission or death of just 1-2 days. Among 628 patients for whom data were available (median age, 76 years [interquartile range, 61-84 years]; 344 men), opacification of 51%-75% increased risk for ICU admission or death by twofold (hazard ratio, 2.2; 95% CI: 1.6, 2.8), and opacification greater than 75% increased ICU risk by fourfold (hazard ratio, 4.0; 95% CI: 3.4, 4.7) compared with opacification of 0%-25%, when adjusted for NEWS2 score. Conclusion Brixia, radiographic assessment of lung edema, and percentage opacification scores all reliably helped predict adverse outcomes in SARS-CoV-2 infection. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Little in this issue.
引用
- Au-Yong I, Higashi Y, Giannotti E, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021. PMID: 34519573. doi:10.1148/radiol.2021210986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。